epcoritamab
genmab,abbvie
['epcore,nhl,1', 'leusm', 'epcore,nhl,i,(-ii)', 'lymsm', 'epcoritamab', 'nhl']
congress #17icml | presented longer follow-up results of epcore nhl-1 study of epcoritamab in pts with lbcl. n=157, epcoritamab showed durable crs with improved outcomes &amp; a manageable safety profile in pts with lbcl #lymsm #leusm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm